Wang, Cun
Vegna, Serena
Jin, Haojie
Benedict, Bente
Lieftink, Cor
Ramirez, Christel
de Oliveira, Rodrigo Leite
Morris, Ben
Gadiot, Jules
Wang, Wei
du Chatinier, Aimée
Wang, Liqin
Gao, Dongmei
Evers, Bastiaan
Jin, Guangzhi
Xue, Zheng
Schepers, Arnout
Jochems, Fleur
Sanchez, Antonio Mulero
Mainardi, Sara
te Riele, Hein
Beijersbergen, Roderick L.
Qin, Wenxin
Akkari, Leila
Bernards, René
Article History
Received: 18 October 2018
Accepted: 21 August 2019
First Online: 2 October 2019
Competing interests
: C.W. and R.B. are listed as inventors of a patent application using the one–two punch therapy (CDC7 inhibitor and mTOR inhibitor) for liver cancers with <i>TP53</i> mutations. R.B. is the founder of the company Oncosence, which exploits pro-senescence therapies for cancer.